Vis enkel innførsel

dc.contributor.authorHelgeland, Øyvind
dc.contributor.authorHertel, Jens Kristoffer
dc.contributor.authorMolven, Anders
dc.contributor.authorRæder, Helge
dc.contributor.authorPlatou, Carl Geoffrey Parrinder
dc.contributor.authorMidthjell, Kristian
dc.contributor.authorHveem, Kristian
dc.contributor.authorNygård, Ottar
dc.contributor.authorNjølstad, Pål Rasmus
dc.contributor.authorJohansson, Stefan
dc.date.accessioned2015-04-08T12:02:01Z
dc.date.accessioned2015-10-20T14:09:18Z
dc.date.available2015-04-08T12:02:01Z
dc.date.available2015-10-20T14:09:18Z
dc.date.issued2015
dc.identifier.citationInternational Journal of Endocrinology 2015nb_NO
dc.identifier.issn1687-8345
dc.identifier.urihttp://hdl.handle.net/11250/2357317
dc.description.abstractBackground. Two adjacent regions upstream CDKN2B on chromosome 9p21 have been associated with type 2 diabetes (T2D) and progression of cardiovascular disease (CVD).The precise location and number of risk variants have not been completely delineated and a possible synergistic relationship between the adjacent regions is not fully addressed. By a population based cross-sectional case-control design, we genotyped 18 SNPs upstream of CDKN2B tagging 138 kb in and around two LD-blocks associated with CVD and T2D and investigated associations with T2D, angina pectoris (AP), myocardial infarction (MI), coronary heart disease (CHD; AP or AMI), and stroke using 5,564 subjects from HUNT2. Results. Single point and haplotype analysis showed evidence for only one common T2D risk haplotype (rs10757282|rs10811661: OR = 1.19, 𝑃? = 2.0 × 10−3) in the region.We confirmed the strong association between SNPs in the 60 kb CVD region with AP, MI, and CHD(𝑃? < 0.01). Conditioning on the lead SNPs in the region, we observed two suggestive independent single SNP association signals for MI, rs2065501 (𝑃? = 0.03) and rs3217986 (𝑃? = 0.04). Conclusions. We confirmed the association of known variants within the 9p21 interval with T2D and CHD. Our results further suggest that additional CHD susceptibility variants exist in this region.nb_NO
dc.language.isoengnb_NO
dc.publisherHindawi Publishing Corporationnb_NO
dc.titleThe Chromosome 9p21 CVD- and T2D-Associated Regions in a Norwegian Population (The HUNT2 Survey)nb_NO
dc.typeJournal articlenb_NO
dc.typePeer revieweden_GB
dc.date.updated2015-04-08T12:02:01Z
dc.subject.nsiVDP::Medisinske fag: 700::Klinisk medisinske fag: 750::Endokrinologi: 774nb_NO
dc.subject.nsiVDP::Midical sciences: 700::Clinical medical sciences: 750::Endocrinology: 774nb_NO
dc.subject.nsiVDP::Medisinske fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710::Medisinsk genetikk: 714nb_NO
dc.subject.nsiVDP::Midical sciences: 700::Basic medical, dental and veterinary sciences: 710::Medical genetics: 714nb_NO
dc.source.journalInternational Journal of Endocrinologynb_NO
dc.identifier.doi10.1155/2015/164652
dc.identifier.cristin1229721
dc.description.localcodeCopyright © Øyvind Helgeland et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.nb_NO


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel